171 related articles for article (PubMed ID: 29079708)
1. miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating
Yang Y; Huang G; Zhou Z; Fewell JG; Kleinerman ES
Mol Cancer Ther; 2018 Jan; 17(1):130-139. PubMed ID: 29079708
[TBL] [Abstract][Full Text] [Related]
2. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.
Huang G; Nishimoto K; Zhou Z; Hughes D; Kleinerman ES
Cancer Res; 2012 Feb; 72(4):908-16. PubMed ID: 22186140
[TBL] [Abstract][Full Text] [Related]
3. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
4. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
Huang G; Nishimoto K; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
[TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
[TBL] [Abstract][Full Text] [Related]
6. VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.
Jia SF; Guan H; Duan X; Kleinerman ES
J Exp Ther Oncol; 2008; 7(2):89-97. PubMed ID: 18771083
[TBL] [Abstract][Full Text] [Related]
7. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
Xu Z; Wang T
Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1.
Duan G; Ren C; Zhang Y; Feng S
Tumour Biol; 2015 Aug; 36(8):6201-9. PubMed ID: 25761878
[TBL] [Abstract][Full Text] [Related]
9. miRNA-20a upregulates TAK1 and increases proliferation in osteosarcoma cells.
Yuan G; Zhao Y; Wu D; Gao C; Jiao Z
Future Oncol; 2018 Feb; 14(5):461-469. PubMed ID: 29327611
[TBL] [Abstract][Full Text] [Related]
10. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
11. MiR-20a triggers metastasis of gallbladder carcinoma.
Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
[TBL] [Abstract][Full Text] [Related]
12. Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases.
Koshkina NV; Rao-Bindal K; Kleinerman ES
Cancer; 2011 Aug; 117(15):3457-67. PubMed ID: 21287529
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
Li Y; Liu J; Liu ZZ; Wei WB
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
[TBL] [Abstract][Full Text] [Related]
14. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.
Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA
J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas.
Yang SF; Lee WJ; Tan P; Tang CH; Hsiao M; Hsieh FK; Chien MH
Oncotarget; 2015 Feb; 6(5):2736-53. PubMed ID: 25605016
[TBL] [Abstract][Full Text] [Related]
16. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
[TBL] [Abstract][Full Text] [Related]
17. miR-20a regulates expression of the iron exporter ferroportin in lung cancer.
Babu KR; Muckenthaler MU
J Mol Med (Berl); 2016 Mar; 94(3):347-59. PubMed ID: 26560875
[TBL] [Abstract][Full Text] [Related]
18. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
Zhang Z; Zhang W; Mao J; Xu Z; Fan M
Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.
Zhu C; Deng X; Wu J; Zhang J; Yang H; Fu S; Zhang Y; Han Y; Zou Y; Chen Z; Lin S
Tumour Biol; 2016 Aug; 37(8):11289-97. PubMed ID: 26951513
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
